| Home | << 1 >> |
|
| Record | |||||
|---|---|---|---|---|---|
| Author | Bousingen, Denis Durand de | ||||
| Title | Drug firm compensates patients for suspected hepatitis B vaccine failure | Type | Journal Article | ||
| Year | 2001 | Publication | The Lancet | Abbreviated Journal | |
| Volume | 357 | Issue | 19.05.2001 | Pages | 1598 |
| Keywords | health promotion; viral hepatitis; hepatitis B | ||||
| Abstract | A French appeal court has ordered GlaxoSmithKline (GSK) to pay US$6686 and US$10 697 in compensation to two women with multiple sclerosis who claim the chronic disease was caused by a hepatitis B vaccine (Engerix B) manufactured by the pharmaceutical company. | ||||
Address  |
|||||
| Corporate Author | Thesis | ||||
| Publisher | Place of Publication | Editor | |||
| Language | English | Summary Language | Original Title | ||
| Series Editor | Series Title | Abbreviated Series Title | |||
| Series Volume | Series Issue | Edition | |||
| ISSN | 0140-6736 | ISBN | Medium | ||
| Area | Expedition | Conference | |||
| Notes | Approved | no | |||
| Call Number | 50-02698 | Serial | 59735 | ||
| Permanent link to this record | |||||